世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
ウェアラブルインジェクター市場。世界の産業動向、シェア、サイズ、成長、機会、そして2021-2026年の予測Wearable Injectors Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026 The global wearable injectors market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 15% during 2021-2026. Keeping in mind the ... もっと見る
サマリーThe global wearable injectors market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 15% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end-use sectors. These insights are included in the report as a major market contributor.Wearable injectors, or patch pumps, are compact drug delivery devices used for single-step administration of medicines for longer durations. They are temporarily pasted on the skin to deliver viscous drugs in large volumes faster and safely through the subcutaneous tissues in the body. They are commonly available in on-body and off-body injector variants and the device consists of a reservoir to store medicine, a cannula for substance delivery to tissues and a drive system to deliver the appropriate drug volume. In comparison to the traditionally used vials and syringes, wearable injectors are disposable, user-friendly, cause minimal discomfort and pain. As a result, they are widely used in the treatment of cancer, diabetes, rheumatoid arthritis and cardiovascular diseases. Wearable Injectors Market Trends: The increasing prevalence of chronic medical ailments, such as oncological, neurological and autoimmune disorders, is of the key factors driving the market growth. Moreover, the rising geriatric population, which is more susceptible to such ailments, and the increasing demand for minimally invasive (MI) treatment alternatives among the patients are providing a thrust to the growth of the market. There is also a growing preference for at-home and self-administrable injectors to effectively manage the ailments with minimal risks of inaccurate dosage and needle stick injuries. Additionally, various product innovations, such as integration of passive warning systems, wireless connectivity and Bluetooth technologies with the injectors, are acting as other growth-inducing factors. These technologies facilitate convenient monitoring of the patient through a smartphone application and provide timely reminders for dosages. Other factors, including extensive research and development activities, along with significant improvements in the healthcare infrastructure, especially in the developing economies, are anticipating to the drive the market toward growth. Key Market Segmentation: IMARC Group provides an analysis of the key trends in each sub-segment of the global wearable injectors market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, type, technology, application and end use. Breakup by Type: On-body Off-body Breakup by Technology: Spring-based Motor-driven Rotary Pump Expanding Battery Others Breakup by Application: Oncology Infectious Diseases Cardiovascular Diseases Autoimmune Diseases Others Breakup by End Use: Hospitals and Clinics Home Care Others Breakup by Region: North America United States Canada Asia-Pacific China Japan India South Korea Australia Indonesia Others Europe Germany France United Kingdom Italy Spain Russia Others Latin America Brazil Mexico Others Middle East and Africa Competitive Landscape: The competitive landscape of the industry has also been examined along with the profiles of the key players being Becton Dickinson and Company, CeQur SA, Debiotech SA, Dexcom Inc., Enable Injections Inc., Gerresheimer AG, Insulet Corporation, Tandem Diabetes Care Inc., West Pharmaceutical Services Inc. and Ypsomed AG. Key Questions Answered in This Report: How has the global wearable injectors market performed so far and how will it perform in the coming years? What has been the impact of COVID-19 on the global wearable injectors market? What are the key regional markets? What is the breakup of the market based on the type? What is the breakup of the market based on the technology? What is the breakup of the market based on the application? What is the breakup of the market based on the end use? What are the various stages in the value chain of the industry? What are the key driving factors and challenges in the industry? What is the structure of the global wearable injectors market and who are the key players? What is the degree of competition in the industry? 目次1 Preface2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Wearable Injectors Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast 6 Market Breakup by Type 6.1 On-body 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Off-body 6.2.1 Market Trends 6.2.2 Market Forecast 7 Market Breakup by Technology 7.1 Spring-based 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Motor-driven 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Rotary Pump 7.3.1 Market Trends 7.3.2 Market Forecast 7.4 Expanding Battery 7.4.1 Market Trends 7.4.2 Market Forecast 7.5 Others 7.5.1 Market Trends 7.5.2 Market Forecast 8 Market Breakup by Application 8.1 Oncology 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 Infectious Diseases 8.2.1 Market Trends 8.2.2 Market Forecast 8.3 Cardiovascular Diseases 8.3.1 Market Trends 8.3.2 Market Forecast 8.4 Autoimmune Diseases 8.4.1 Market Trends 8.4.2 Market Forecast 8.5 Others 8.5.1 Market Trends 8.5.2 Market Forecast 9 Market Breakup by End Use 9.1 Hospitals and Clinics 9.1.1 Market Trends 9.1.2 Market Forecast 9.2 Home Care 9.2.1 Market Trends 9.2.2 Market Forecast 9.3 Others 9.3.1 Market Trends 9.3.2 Market Forecast 10 Market Breakup by Region 10.1 North America 10.1.1 United States 10.1.1.1 Market Trends 10.1.1.2 Market Forecast 10.1.2 Canada 10.1.2.1 Market Trends 10.1.2.2 Market Forecast 10.2 Asia-Pacific 10.2.1 China 10.2.1.1 Market Trends 10.2.1.2 Market Forecast 10.2.2 Japan 10.2.2.1 Market Trends 10.2.2.2 Market Forecast 10.2.3 India 10.2.3.1 Market Trends 10.2.3.2 Market Forecast 10.2.4 South Korea 10.2.4.1 Market Trends 10.2.4.2 Market Forecast 10.2.5 Australia 10.2.5.1 Market Trends 10.2.5.2 Market Forecast 10.2.6 Indonesia 10.2.6.1 Market Trends 10.2.6.2 Market Forecast 10.2.7 Others 10.2.7.1 Market Trends 10.2.7.2 Market Forecast 10.3 Europe 10.3.1 Germany 10.3.1.1 Market Trends 10.3.1.2 Market Forecast 10.3.2 France 10.3.2.1 Market Trends 10.3.2.2 Market Forecast 10.3.3 United Kingdom 10.3.3.1 Market Trends 10.3.3.2 Market Forecast 10.3.4 Italy 10.3.4.1 Market Trends 10.3.4.2 Market Forecast 10.3.5 Spain 10.3.5.1 Market Trends 10.3.5.2 Market Forecast 10.3.6 Russia 10.3.6.1 Market Trends 10.3.6.2 Market Forecast 10.3.7 Others 10.3.7.1 Market Trends 10.3.7.2 Market Forecast 10.4 Latin America 10.4.1 Brazil 10.4.1.1 Market Trends 10.4.1.2 Market Forecast 10.4.2 Mexico 10.4.2.1 Market Trends 10.4.2.2 Market Forecast 10.4.3 Others 10.4.3.1 Market Trends 10.4.3.2 Market Forecast 10.5 Middle East and Africa 10.5.1 Market Trends 10.5.2 Market Breakup by Country 10.5.3 Market Forecast 11 SWOT Analysis 11.1 Overview 11.2 Strengths 11.3 Weaknesses 11.4 Opportunities 11.5 Threats 12 Value Chain Analysis 13 Porters Five Forces Analysis 13.1 Overview 13.2 Bargaining Power of Buyers 13.3 Bargaining Power of Suppliers 13.4 Degree of Competition 13.5 Threat of New Entrants 13.6 Threat of Substitutes 14 Price Analysis 15 Competitive Landscape 15.1 Market Structure 15.2 Key Players 15.3 Profiles of Key Players 15.3.1 Becton Dickinson and Company 15.3.1.1 Company Overview 15.3.1.2 Product Portfolio 15.3.1.3 Financials 15.3.1.4 SWOT Analysis 15.3.2 CeQur SA 15.3.2.1 Company Overview 15.3.2.2 Product Portfolio 15.3.3 Debiotech SA 15.3.3.1 Company Overview 15.3.3.2 Product Portfolio 15.3.4 Dexcom Inc. 15.3.4.1 Company Overview 15.3.4.2 Product Portfolio 15.3.4.3 Financials 15.3.4.4 SWOT Analysis 15.3.5 Enable Injections Inc. 15.3.5.1 Company Overview 15.3.5.2 Product Portfolio 15.3.6 Gerresheimer AG 15.3.6.1 Company Overview 15.3.6.2 Product Portfolio 15.3.6.3 Financials 15.3.7 Insulet Corporation 15.3.7.1 Company Overview 15.3.7.2 Product Portfolio 15.3.7.3 Financials 15.3.7.4 SWOT Analysis 15.3.8 Tandem Diabetes Care Inc. 15.3.8.1 Company Overview 15.3.8.2 Product Portfolio 15.3.8.3 Financials 15.3.9 West Pharmaceutical Services Inc. 15.3.9.1 Company Overview 15.3.9.2 Product Portfolio 15.3.9.3 Financials 15.3.10 Ypsomed AG 15.3.10.1 Company Overview 15.3.10.2 Product Portfolio 15.3.10.3 Financials 15.3.10.4 SWOT Analysis
SummaryThe global wearable injectors market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 15% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end-use sectors. These insights are included in the report as a major market contributor.Wearable injectors, or patch pumps, are compact drug delivery devices used for single-step administration of medicines for longer durations. They are temporarily pasted on the skin to deliver viscous drugs in large volumes faster and safely through the subcutaneous tissues in the body. They are commonly available in on-body and off-body injector variants and the device consists of a reservoir to store medicine, a cannula for substance delivery to tissues and a drive system to deliver the appropriate drug volume. In comparison to the traditionally used vials and syringes, wearable injectors are disposable, user-friendly, cause minimal discomfort and pain. As a result, they are widely used in the treatment of cancer, diabetes, rheumatoid arthritis and cardiovascular diseases. Wearable Injectors Market Trends: The increasing prevalence of chronic medical ailments, such as oncological, neurological and autoimmune disorders, is of the key factors driving the market growth. Moreover, the rising geriatric population, which is more susceptible to such ailments, and the increasing demand for minimally invasive (MI) treatment alternatives among the patients are providing a thrust to the growth of the market. There is also a growing preference for at-home and self-administrable injectors to effectively manage the ailments with minimal risks of inaccurate dosage and needle stick injuries. Additionally, various product innovations, such as integration of passive warning systems, wireless connectivity and Bluetooth technologies with the injectors, are acting as other growth-inducing factors. These technologies facilitate convenient monitoring of the patient through a smartphone application and provide timely reminders for dosages. Other factors, including extensive research and development activities, along with significant improvements in the healthcare infrastructure, especially in the developing economies, are anticipating to the drive the market toward growth. Key Market Segmentation: IMARC Group provides an analysis of the key trends in each sub-segment of the global wearable injectors market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, type, technology, application and end use. Breakup by Type: On-body Off-body Breakup by Technology: Spring-based Motor-driven Rotary Pump Expanding Battery Others Breakup by Application: Oncology Infectious Diseases Cardiovascular Diseases Autoimmune Diseases Others Breakup by End Use: Hospitals and Clinics Home Care Others Breakup by Region: North America United States Canada Asia-Pacific China Japan India South Korea Australia Indonesia Others Europe Germany France United Kingdom Italy Spain Russia Others Latin America Brazil Mexico Others Middle East and Africa Competitive Landscape: The competitive landscape of the industry has also been examined along with the profiles of the key players being Becton Dickinson and Company, CeQur SA, Debiotech SA, Dexcom Inc., Enable Injections Inc., Gerresheimer AG, Insulet Corporation, Tandem Diabetes Care Inc., West Pharmaceutical Services Inc. and Ypsomed AG. Key Questions Answered in This Report: How has the global wearable injectors market performed so far and how will it perform in the coming years? What has been the impact of COVID-19 on the global wearable injectors market? What are the key regional markets? What is the breakup of the market based on the type? What is the breakup of the market based on the technology? What is the breakup of the market based on the application? What is the breakup of the market based on the end use? What are the various stages in the value chain of the industry? What are the key driving factors and challenges in the industry? What is the structure of the global wearable injectors market and who are the key players? What is the degree of competition in the industry? Table of Contents1 Preface2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Wearable Injectors Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast 6 Market Breakup by Type 6.1 On-body 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Off-body 6.2.1 Market Trends 6.2.2 Market Forecast 7 Market Breakup by Technology 7.1 Spring-based 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Motor-driven 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Rotary Pump 7.3.1 Market Trends 7.3.2 Market Forecast 7.4 Expanding Battery 7.4.1 Market Trends 7.4.2 Market Forecast 7.5 Others 7.5.1 Market Trends 7.5.2 Market Forecast 8 Market Breakup by Application 8.1 Oncology 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 Infectious Diseases 8.2.1 Market Trends 8.2.2 Market Forecast 8.3 Cardiovascular Diseases 8.3.1 Market Trends 8.3.2 Market Forecast 8.4 Autoimmune Diseases 8.4.1 Market Trends 8.4.2 Market Forecast 8.5 Others 8.5.1 Market Trends 8.5.2 Market Forecast 9 Market Breakup by End Use 9.1 Hospitals and Clinics 9.1.1 Market Trends 9.1.2 Market Forecast 9.2 Home Care 9.2.1 Market Trends 9.2.2 Market Forecast 9.3 Others 9.3.1 Market Trends 9.3.2 Market Forecast 10 Market Breakup by Region 10.1 North America 10.1.1 United States 10.1.1.1 Market Trends 10.1.1.2 Market Forecast 10.1.2 Canada 10.1.2.1 Market Trends 10.1.2.2 Market Forecast 10.2 Asia-Pacific 10.2.1 China 10.2.1.1 Market Trends 10.2.1.2 Market Forecast 10.2.2 Japan 10.2.2.1 Market Trends 10.2.2.2 Market Forecast 10.2.3 India 10.2.3.1 Market Trends 10.2.3.2 Market Forecast 10.2.4 South Korea 10.2.4.1 Market Trends 10.2.4.2 Market Forecast 10.2.5 Australia 10.2.5.1 Market Trends 10.2.5.2 Market Forecast 10.2.6 Indonesia 10.2.6.1 Market Trends 10.2.6.2 Market Forecast 10.2.7 Others 10.2.7.1 Market Trends 10.2.7.2 Market Forecast 10.3 Europe 10.3.1 Germany 10.3.1.1 Market Trends 10.3.1.2 Market Forecast 10.3.2 France 10.3.2.1 Market Trends 10.3.2.2 Market Forecast 10.3.3 United Kingdom 10.3.3.1 Market Trends 10.3.3.2 Market Forecast 10.3.4 Italy 10.3.4.1 Market Trends 10.3.4.2 Market Forecast 10.3.5 Spain 10.3.5.1 Market Trends 10.3.5.2 Market Forecast 10.3.6 Russia 10.3.6.1 Market Trends 10.3.6.2 Market Forecast 10.3.7 Others 10.3.7.1 Market Trends 10.3.7.2 Market Forecast 10.4 Latin America 10.4.1 Brazil 10.4.1.1 Market Trends 10.4.1.2 Market Forecast 10.4.2 Mexico 10.4.2.1 Market Trends 10.4.2.2 Market Forecast 10.4.3 Others 10.4.3.1 Market Trends 10.4.3.2 Market Forecast 10.5 Middle East and Africa 10.5.1 Market Trends 10.5.2 Market Breakup by Country 10.5.3 Market Forecast 11 SWOT Analysis 11.1 Overview 11.2 Strengths 11.3 Weaknesses 11.4 Opportunities 11.5 Threats 12 Value Chain Analysis 13 Porters Five Forces Analysis 13.1 Overview 13.2 Bargaining Power of Buyers 13.3 Bargaining Power of Suppliers 13.4 Degree of Competition 13.5 Threat of New Entrants 13.6 Threat of Substitutes 14 Price Analysis 15 Competitive Landscape 15.1 Market Structure 15.2 Key Players 15.3 Profiles of Key Players 15.3.1 Becton Dickinson and Company 15.3.1.1 Company Overview 15.3.1.2 Product Portfolio 15.3.1.3 Financials 15.3.1.4 SWOT Analysis 15.3.2 CeQur SA 15.3.2.1 Company Overview 15.3.2.2 Product Portfolio 15.3.3 Debiotech SA 15.3.3.1 Company Overview 15.3.3.2 Product Portfolio 15.3.4 Dexcom Inc. 15.3.4.1 Company Overview 15.3.4.2 Product Portfolio 15.3.4.3 Financials 15.3.4.4 SWOT Analysis 15.3.5 Enable Injections Inc. 15.3.5.1 Company Overview 15.3.5.2 Product Portfolio 15.3.6 Gerresheimer AG 15.3.6.1 Company Overview 15.3.6.2 Product Portfolio 15.3.6.3 Financials 15.3.7 Insulet Corporation 15.3.7.1 Company Overview 15.3.7.2 Product Portfolio 15.3.7.3 Financials 15.3.7.4 SWOT Analysis 15.3.8 Tandem Diabetes Care Inc. 15.3.8.1 Company Overview 15.3.8.2 Product Portfolio 15.3.8.3 Financials 15.3.9 West Pharmaceutical Services Inc. 15.3.9.1 Company Overview 15.3.9.2 Product Portfolio 15.3.9.3 Financials 15.3.10 Ypsomed AG 15.3.10.1 Company Overview 15.3.10.2 Product Portfolio 15.3.10.3 Financials 15.3.10.4 SWOT Analysis
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（産業機械）の最新刊レポート
IMARC Services Private Limited.社のその他分野での最新刊レポート
本レポートと同じKEY WORD（wearable）の最新刊レポート
よくあるご質問IMARC Services Private Limited.社はどのような調査会社ですか?インドに調査拠点を持つ調査会社。幅広い分野をカバーしていますがケミカルに特に焦点を当てています。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
